- Home
- ATRA vs SVT Comparison
ATRA vs SVT Comparison
Compare ATRA & SVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- SVT
- Stock Information
- Founded
- ATRA 2012
- SVT 1959
- Country
- ATRA United States
- SVT United States
- Employees
- ATRA N/A
- SVT N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- SVT Industrial Machinery/Components
- Sector
- ATRA Health Care
- SVT Consumer Discretionary
- Exchange
- ATRA Nasdaq
- SVT Nasdaq
- Market Cap
- ATRA 43.4M
- SVT N/A
- IPO Year
- ATRA 2014
- SVT N/A
- Fundamental
- Price
- ATRA $9.27
- SVT $12.04
- Analyst Decision
- ATRA Hold
- SVT
- Analyst Count
- ATRA 6
- SVT 0
- Target Price
- ATRA $24.88
- SVT N/A
- AVG Volume (30 Days)
- ATRA 90.7K
- SVT 1.4K
- Earning Date
- ATRA 10-30-2024
- SVT 11-07-2024
- Dividend Yield
- ATRA N/A
- SVT N/A
- EPS Growth
- ATRA N/A
- SVT N/A
- EPS
- ATRA N/A
- SVT 0.17
- Revenue
- ATRA $62,387,000.00
- SVT $46,639,000.00
- Revenue This Year
- ATRA $1,190.80
- SVT N/A
- Revenue Next Year
- ATRA N/A
- SVT N/A
- P/E Ratio
- ATRA N/A
- SVT $41.96
- Revenue Growth
- ATRA 809.03
- SVT 26.13
- 52 Week Low
- ATRA $4.98
- SVT $8.80
- 52 Week High
- ATRA $39.50
- SVT $14.10
- Technical
- Relative Strength Index (RSI)
- ATRA 63.04
- SVT 51.82
- Support Level
- ATRA $7.55
- SVT $11.39
- Resistance Level
- ATRA $10.05
- SVT $12.83
- Average True Range (ATR)
- ATRA 0.51
- SVT 0.20
- MACD
- ATRA 0.21
- SVT 0.07
- Stochastic Oscillator
- ATRA 72.63
- SVT 44.81
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).